NCT02638987

Brief Summary

An experimental study will be conducted to evaluate the effect of a single dry needling session on surface EMG activity (primary outcome measure), muscle tone, elasticity, stiffness and pain (secondary outcome measures) of the upper trapezius, in female office workers with trapezius myalgia.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2015

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 9, 2015

Completed
14 days until next milestone

First Posted

Study publicly available on registry

December 23, 2015

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2016

Completed
Last Updated

December 5, 2022

Status Verified

November 1, 2022

Enrollment Period

4 months

First QC Date

December 9, 2015

Last Update Submit

November 30, 2022

Conditions

Keywords

Dry needlingoffice workersmyofascial painelectromyography

Outcome Measures

Primary Outcomes (1)

  • Changes in surface resting EMG activity of the upper trapezius after dry needling as assessed by the EMG DTS device

    Device: Noraxon USA Desktop Direct Transmission System (DTS) for EMG Changes in resting EMG activity of the upper trapezius immediately after dry needling and 10 minutes after dry needling, compared to resting EMG activity after a typing task, will be measured by using surface electrodes placed bilaterally at the MTrP 2 location of the upper trapezius (halfway between C7 and the posterolateral edge of the acromion). The change in EMG activity after dry needling will be compared with the change in EMG activity after rest. Resting EMG activity will be expressed as a percentage of submaximal reference contractions of the upper trapezius (% reference contractions).

    Immediately after a typing task of 20 minutes, one minute after dry needling, 10 minutes after dry needling

Secondary Outcomes (12)

  • Changes in surface resting EMG activity of the upper trapezius after rest as assessed by the EMG DTS device

    Immediately after a typing task of 20 minutes, immediately after a resting pause of 10 minutes

  • Changes in surface resting EMG activity of the upper trapezius during a fatiguing typing task of 20 minutes as assessed by the EMG DTS device

    During the typing task, every five minutes EMG activity will be measured for 30 seconds

  • Differences in active muscle tension of the upper trapezius (ratio between resting EMG activity in upright and lying position) between the (dominant) painful and heterolateral side, as assessed by the EMG DTS device

    At baseline

  • Differences in muscle fatigue of the upper trapezius (ratio between resting EMG activity before and after a typing task of 20 minutes) between the (dominant) painful and heterolateral side, as assessed by the EMG DTS device

    Before and after a typing task of 20 minutes

  • Changes in muscle tone, stiffness and elasticity of the upper trapezius after dry needling as assessed by the MyotonPRO ®

    Immediately after a typing task of 20 minutes, one minute after dry needling, 10 minutes after dry needling

  • +7 more secondary outcomes

Study Arms (2)

Dry needling

EXPERIMENTAL

After the second computer task, a single dry needling session will be performed with the subject lying on the non painful side. After palpation of a taut band and detection of MTrP 2 in the upper trapezius muscle, a trained physiotherapist will penetrate the needle into the MTrP and will move the needle up and down in multiple directions. When local twitch responses are elicited, this will be repeated until the local twitch responses are extinct.

Procedure: Dry needling

Rest

NO INTERVENTION

After the first computer task, participants will rest in sidelying position for 10 minutes.

Interventions

Dry needlingPROCEDURE

Dry needling (DN) is a myofascial treatment technique, in which a thin, solid filiform needle is inserted directly into the MTrP. During dry needling, local twitch responses (LTR) can be elicited. These are involuntary contractions of muscle fibers, leading to muscle relaxation, an increase in blood flow,recovery of the muscle metabolism and thus a reduction of pain and stiffness.

Dry needling

Eligibility Criteria

Age25 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Performing office work since at least one year
  • Performing computer based tasks for at least 20 hours a week
  • NRS \> or equal to 3/10
  • Clinical diagnosis of trapezius myalgia
  • Trapezius myalgia is work-related and thus aggravates during working day/week
  • Presence of MTrP2 in the upper trapezius muscle (bilaterally)

You may not qualify if:

  • Being in treatment during the study
  • Traumatic injuries/surgery to neck and upper limb region
  • Signs of cervical nerve root impingement
  • Whiplash injury
  • Cardiovascular, neurological, life threatening, systemic and metabolic diseases
  • Diagnosis of fibromyalgia/chronic fatigue syndrome
  • Shoulder pathology
  • Coagulation disorders
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Neck Pain

Interventions

Dry Needling

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy Modalities

Study Officials

  • Barbara Cagnie, PhD

    University Ghent

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2015

First Posted

December 23, 2015

Study Start

September 1, 2015

Primary Completion

January 1, 2016

Study Completion

January 1, 2016

Last Updated

December 5, 2022

Record last verified: 2022-11